The potential role of gut-derived inflammation in multiple system atrophy

Journal of Parkinson's Disease

Volumn 7, Issue 2, 2017, Pages 331-346

  Engen, Phillip A ^a   Dodiya, Hemraj B ^a   Naqib, Ankur ^c   Forsyth, Christopher B ^a   Green, Stefan J ^c   Voigt, Robin M ^a   Kordower, Jeffrey H ^a   Mutlu, Ece A ^a   Shannon, Kathleen M ^b   Keshavarzian, Ali ^a,d  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^c UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^d UTRECHT UNIVERSITY   (Netherlands)

Author keywords

Colonic mucosa and feces; Lipopolysaccharide; Microbiota; Multiple system atrophy; Tolllike receptor 4; Zonula Occludens 1

Indexed keywords

ENDOTOXIN; LIPOPOLYSACCHARIDE; PROTEIN ZO1; RNA 16S; TOLL LIKE RECEPTOR 4; TJP1 PROTEIN, HUMAN; TLR4 PROTEIN, HUMAN;

AMPLICON; ARTICLE; BACTERIAL GENE; BACTEROIDETES; CLINICAL ARTICLE; COLON MUCOSA; CONTROLLED STUDY; ENTERITIS; FECES MICROFLORA; GENUS; GRAM NEGATIVE BACTERIUM; HIGH THROUGHPUT SEQUENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MICROORGANISM DETECTION; NONHUMAN; POPULATION ABUNDANCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN STRUCTURE; PROTEOBACTERIA; SHY DRAGER SYNDROME; SIGMOID; SMALL INTESTINE TISSUE; SPECIES COMPOSITION; TAXONOMY; COMPLICATION; FECES; FEMALE; INFLAMMATION; INTESTINE FLORA; MALE; METABOLISM; MICROBIOLOGY; PATHOLOGY;

COLON, SIGMOID; FECES; FEMALE; GASTROINTESTINAL MICROBIOME; HUMANS; INFLAMMATION; MALE; MULTIPLE SYSTEM ATROPHY; TOLL-LIKE RECEPTOR 4; ZONULA OCCLUDENS-1 PROTEIN;

EID: 85019188937     PISSN: 18777171     EISSN: 1877718X     Source Type: Journal    
DOI: 10.3233/JPD-160991     Document Type: Article

References (100)

1. Graham JG, & Oppenheimer DR (1969) Orthostatic hypotension and nicotine sensitivity in a case of multiple system atrophy. J Neurol Neurosurg Psychiatry, 32, 28-34.
2. Bannister R, & Oppenheimer DR (1972) Degenerative diseases of the nervous system associated with autonomic failure. Brain, 95, 457-474.
3. Gilman S, Wenning GK, Low PA, Brooks DJ, Mathias CJ, Trojanowski JQ, Wood NW, Colosimo C, Durr A, Fowler CJ, Kaufmann H, Klockgether T, Lees A, Poewe W, Quinn N, Revesz T, Robertson D, Sandroni P, Seppi K, & Vidailhet M (2008) Second consensus statement on the diagnosis of multiple system atrophy. Neurology, 71, 670-676.
4. Geser F, Wenning GK, Seppi K, Stampfer-Kountchev M, Scherfler C, Sawires M, Frick C, Ndayisaba JP, Ulmer H, Pellecchia MT, Barone P, Kim HT, Hooker J, Quinn NP, Cardozo A, Tolosa E, Abele M, Klockgether T, Ostergaard K, Dupont E, Schimke N, Eggert KM, OertelW, Djaldetti R, & Poewe W (2006) Progression of multiple system atrophy (MSA): A prospective natural history study by the European MSA Study Group (EMSA SG). Mov Disord, 21, 179-186.
5. Stefanova N, Bucke P, Duerr S, & Wenning GK (2009) Multiple system atrophy: An update. Lancet Neurol, 8, 1172-1178.
6. Quinn N (2015) Ashort clinical history of multiple system atrophy. Clin Auton Res, 25(1), 3-7.
7. Shy GM, & Drager GA (1960) A neurological syndrome associated with orthostatic hypotension: A clinicalpathologic study. Arch Neurol, 2, 511-527.
8. Kollensperger M, Geser F, Seppi K, Stampfer-Kountchev M, Sawires M, Scherfler C, Boesch S, Mueller J, Koukouni V, Quinn N, Pellecchia MT, Barone P, Schimke N, Dodel R, OertelW, Dupont E, Ostergaard K, Daniels C, Deuschl G, Gurevich T, Giladi N, Coelho M, Sampaio C, Nilsson C, Widner H, Sorbo FD, Albanese A, Cardozo A, Tolosa E, Abele M, Klockgether T, Kamm C, Gasser T, Djaldetti R, Colosimo C, Meco G, Schrag A, PoeweW, & Wenning GK (2008) Red flags for multiple system atrophy. Mov Disord, 23, 1093-1099.
9. Forsyth CB, Shannon KM, Kordower JH, Voigt RM, Shaikh M, Jaglin JA, Estes JD, Dodiya HB, & Keshavarzian A (2011) Increased intestinal permeability correlates with sigmoid mucosa alpha-synuclein staining and endotoxin exposure markers in early Parkinson's disease. PLoS One, 6, e28032.
10. Keshavarzian A, Green SJ, Engen PA, Voigt RM, Naqib A, Forsyth CB, Mutlu E, & Shannon KM (2015) Colonic bacterial composition in Parkinson's disease. Mov Disord, 30, 1351-1360.
11. Sampson TR, Debelius JW, Thron T, Janssen S, Shastri GG, Ilhan ZE, Challis C, Schretter CE, Rocha S, Gradinaru V, Chesselet MF, Keshavarzian A, Shannon KM, Krajmalnik-Brown R, Wittung-Stafshede P, Knight R, & Mazmanian SK (2016) Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson's disease. Cell, 167, 1469-1480 e1412.
12. Scheperjans F, Aho V, Pereira PA, Koskinen K, Paulin L, Pekkonen E, Haapaniemi E, Kaakkola S, Eerola-Rautio J, Pohja M, Kinnunen E, Murros K, & Auvinen P (2015) Gut microbiota are related to Parkinson's disease and clinical phenotype. Mov Disord, 30, 350-358.
13. Stefanova N, Reindl M, Neumann M, Kahle PJ, Poewe W, & Wenning GK (2007) Microglial activation mediates neurodegeneration related to oligodendroglial alpha-synucleinopathy: Implications for multiple system atrophy. Mov Disord, 22, 2196-2203.
14. Kim C, Ho DH, Suk JE, You S, Michael S, Kang J, Joong Lee S, Masliah E, Hwang D, Lee HJ, & Lee SJ (2013) Neuron-released oligomeric alpha-synuclein is an endogenous agonist ofTLR2for paracrine activation of microglia. Nat Commun, 4, 1562.
15. Fellner L, Irschick R, Schanda K, Reindl M, Klimaschewski L, Poewe W, Wenning GK, & Stefanova N (2013) Toll-like receptor 4 is required for alpha-synuclein dependent activation of microglia and astroglia. Glia, 61, 349-360.
16. Brudek T, Winge K, Agander TK, & Pakkenberg B (2013) Screening of Toll-like receptors expression in multiple system atrophy brains. Neurochem Res, 38, 1252-1259.
17. Stefanova N, Klimaschewski L, Poewe W, Wenning GK, & Reindl M (2001) Glial cell death induced by overexpression of alpha-synuclein. J Neurosci Res, 65, 432-438.
18. Wang Y, & Kasper LH (2014) The role of microbiome in central nervous system disorders. Brain Behav Immun, 38, 1-12.
19. Kelly JR, Borre Y, C OB, Patterson E, El Aidy S, Deane J, Kennedy PJ, Beers S, Scott K, Moloney G, Hoban AE, Scott L, Fitzgerald P, Ross P, Stanton C, Clarke G, Cryan JF, & Dinan, TG (2016) Transferring the blues: Depression-associated gut microbiota induces neurobehavioural changes in the rat. J Psychiatr Res, 82, 109-118.
20. Pistollato F, Sumalla Cano S, Elio I, Masias Vergara M, Giampieri F, & Battino M (2016) Role of gut microbiota and nutrients in amyloid formation and pathogenesis of Alzheimer disease. Nutr Rev, 74, 624-634.
21. Bruck D, Wenning GK, Stefanova N, & Fellner L (2016) Glia and alpha-synuclein in neurodegeneration: A complex interaction. Neurobiol Dis, 85, 262-274.
22. Bardoux N, Leroi AM, Touchais JY, Weber J, & Denis P (1997) Difficult defaecation and/or faecal incontinence as a presenting feature of neurologic disorders in four patients. Neurogastroenterol Motil, 9, 13-18.
23. Mathias CJ (2006) Multiple system atrophy and autonomic failure. J Neural Transm Suppl, 343-347.
24. Geser F, Seppi K, Stampfer-Kountchev M, Kollensperger M, Diem A, Ndayisaba JP, Ostergaard K, Dupont E, Cardozo A, Tolosa E, Abele M, Dodel R, Klockgether T, Ghorayeb I, Yekhlef F, Tison F, Daniels C, Kopper F, Deuschl G, Coelho M, Ferreira J, Rosa MM, Sampaio C, Bozi M, Schrag A, Hooker J, Kim H, Scaravilli T, Mathias CJ, Fowler C, Wood N, Quinn N, Widner H, Nilsson CF, Lindvall O, Schimke N, Eggert KM, Oertel W, del Sorbo F, Carella F, Albanese A, Pellecchia MT, Barone P, Djaldetti R, Meco G, Colosimo C, Gonzalez-Mandly A, Berciano J, Gurevich T, Giladi N, Galitzky M, Ory F, Rascol O, Kamm C, Buerk K, Maass S, Gasser T, PoeweW, & Wenning GK (2005) The European Multiple System Atrophy-Study Group (EMSA-SG). J Neural Transm (Vienna), 112, 1677-1686.
25. Yamamoto T, Sakakibara R, Uchiyama T, Yamaguchi C, Nomura F, Ito T, Yanagisawa M, Yano M, Awa Y, Yamanishi T, Hattori T, & Kuwabara S (2011) Pelvic organ dysfunction is more prevalent and severe in MSA-P compared to Parkinson's disease. Neurourol Urodyn, 30, 102-107.
26. Colosimo C, Morgante L, Antonini A, Barone P, Avarello TP, Bottacchi E, Cannas A, Ceravolo MG, Ceravolo R, Cicarelli G, Gaglio RM, Giglia L, Iemolo F, Manfredi M, Meco G, Nicoletti A, Pederzoli M, Petrone A, Pisani A, Pontieri FE, Quatrale R, Ramat S, Scala R, Volpe G, Zappulla S, Bentivoglio AR, Stocchi F, Trianni G, Del Dotto P, Simoni L, & Marconi R (2010) Non-motor symptoms in atypical and secondary parkinsonism: The PRIAMO study. J Neurol, 257, 5-14.
27. Tanaka Y, Kato T, Nishida H, Yamada M, Koumura A, Sakurai T, Hayashi Y, Kimura A, Hozumi I, Araki H, Murase M, Nagaki M, Moriwaki H, & Inuzuka T (2012) Is there delayed gastric emptying in patients with multiple system atrophy? An analysis using the (13)C-acetate breath test. J Neurol, 259, 1448-1452.
28. Thomaides T, Karapanayiotides T, Zoukos Y, Haeropoulos C, Kerezoudi E, Demacopoulos N, Floodas G, Papageorgiou E, Armakola F, Thomopoulos Y, & Zaloni I (2005) Gastric emptying after semi-solid food in multiple system atrophy and Parkinson disease. J Neurol, 252, 1055-1059.
29. Sakakibara R, Odaka T, Uchiyama T, Liu R, Asahina M, Yamaguchi K, Yamaguchi T, Yamanishi T, & Hattori T (2004) Colonic transit time, sphincter EMG, and rectoanal videomanometry in multiple system atrophy. Mov Disord, 19, 924-929.
30. Winge K, Jennum P, Lokkegaard A, & Werdelin L (2010) Anal sphincter EMG in the diagnosis of parkinsonian syndromes. Acta Neurol Scand, 121, 198-203.
31. Ravits J, Hallett M, Nilsson J, Polinsky R, & Dambrosia J (1996) Electrophysiological tests of autonomic function in patients with idiopathic autonomic failure syndromes. Muscle Nerve, 19, 758-763.
32. Ozawa T, Saji E, Yajima R, Onodera O, & Nishizawa M (2010) Reduced bowel sounds in Parkinson's disease and multiple system atrophy patients. Clin Auton Res, 21, 181-184.
33. Hughes AJ, Daniel SE, Kilford L, & Lees AJ (1992) Accuracy of clinical diagnosis of idiopathic Parkinson's disease: A clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry, 55, 181-184.
34. O'Connor PG, & Schottenfeld RS (1998) Patients with alcohol problems. N Engl J Med, 338, 592-602.
35. Lotfipour S, Howard J, Roumani S, Hoonpongsimanont W, Chakravarthy B, Anderson CL, Weiss JW, Cisneros V, & Dykzeul B (2013) Increased detection of alcohol consumption and at-risk drinking with computerized alcohol screening. J Emerg Med, 44, 861-866.
36. Shannon KM, Keshavarzian A, Mutlu E, Dodiya HB, Daian D, Jaglin JA, & Kordower JH (2012) Alphasynuclein in colonic submucosa in early untreated Parkinson's disease. Mov Disord, 27, 709-715.
37. Dodiya HB, Bjorklund T, Stansell J, 3rd, Mandel RJ, Kirik D, & Kordower JH (2010) Differential transduction following basal ganglia administration of distinct pseudotyped AAV capsid serotypes in nonhuman primates. Mol Ther, 18, 579-587.
38. Mayhew TM (1991) The new stereological methods for interpreting functional morphology from slices of cells and organs. Exp Physiol, 76, 639-665.
39. Gundersen HJ, Bendtsen TF, Korbo L, Marcussen N, Moller A, Nielsen K, Nyengaard JR, Pakkenberg B, Sorensen FB, & Vesterby A, et al. (1988) Some new, simple and efficient stereological methods and their use in pathological research and diagnosis. APMIS, 96, 379-394.
40. Caporaso JG, Lauber CL, Walters WA, Berg-Lyons D, Huntley J, Fierer N, Owens SM, Betley J, Fraser L, Bauer M, Gormley N, Gilbert JA, Smith G, & Knight R (2012) Ultra-high-throughput microbial community analysis on the Illumina HiSeq and MiSeq platforms. ISME J, 6, 1621-1624.
41. Edgar RC (2010) Search and clustering orders of magnitude faster than BLAST. Bioinformatics, 26, 2460-2461.
42. Caporaso JG, Kuczynski J, Stombaugh J, Bittinger K, Bushman FD, Costello EK, Fierer N, Pena AG, Goodrich JK, Gordon JI, Huttley GA, Kelley ST, Knights D, Koenig JE, Ley RE, Lozupone CA, McDonald D, Muegge BD, Pirrung M, Reeder J, Sevinsky JR, Turnbaugh PJ, Walters WA, Widmann J, Yatsunenko T, Zaneveld J, & Knight R (2010) QIIME allows analysis of high-throughput community sequencing data. Nat Methods, 7, 335-336.
43. Gihring TM, Green SJ, & Schadt CW (2012) Massively parallel rRNA gene sequencing exacerbates the potential for biased community diversity comparisons due to variable library sizes. Environ Microbiol, 14, 285-290.
44. McDonald D, Clemente JC, Kuczynski J, Rideout JR, Stombaugh J, Wendel D, Wilke A, Huse S, Hufnagle J, Meyer F, Knight R, & Caporaso JG (2012) The Biological Observation Matrix (BIOM) format or: How I learned to stop worrying and love the ome-ome. Gigascience, 1, 7.
45. Clarke KR (1993) Non-parametric multivariate analyses of changes in community structure. Aust J Ecol, 18, 117-143.
46. Langille MG, Zaneveld J, Caporaso JG, McDonald D, Knights D, Reyes JA, Clemente JC, Burkepile DE, Vega Thurber RL, Knight R, Beiko RG, & Huttenhower C (2013) Predictive functional profiling of microbial communities using 16S rRNA marker gene sequences. Nat Biotechnol, 31, 814-821.
47. Kanehisa M, & Goto S (2000) KEGG:Kyoto encyclopedia of genes and genomes. Nucleic Acids Res, 28, 27-30.
48. Kanehisa M, Goto S, Sato Y, Furumichi M, & Tanabe M (2011) KEGG for integration and interpretation of largescale molecular data sets. Nucleic Acids Res, 40, D109-D114.
49. Canani RB, Costanzo MD, Leone L, Pedata M, Meli R, & Calignano A (2011) Potential beneficial effects of butyrate in intestinal and extraintestinal diseases. World J Gastroenterol, 17, 1519-1528.
50. Louis P, & Flint HJ (2009) Diversity, metabolism and microbial ecology of butyrate-producing bacteria from the human large intestine. FEMS Microbiol Lett, 294, 1-8.
51. Macfarlane S, & Macfarlane GT (2003) Regulation of short-chain fatty acid production. Proc Nutr Soc, 62, 67-72.
52. Hakansson A, & Molin G (2011) Gut microbiota and inflammation. Nutrients, 3, 637-682.
53. Wexler HM (2007) Bacteroides: The good, the bad, and the nitty-gritty. Clin Microbiol Rev, 20, 593-621.
54. Durban A, Abellan JJ, Jimenez-Hernandez N, Ponce M, Ponce J, Sala T, D'Auria G, Latorre A, & Moya A (2010) Assessing gut microbial diversity from feces and rectal mucosa. Microb Ecol, 61, 123-133.
55. Jankovic J, McDermott M, Carter J, Gauthier S, Goetz C, Golbe L, Huber S, KollerW, Olanow C, & Shoulson I, et al. (1990) Variable expression of Parkinson's disease: A base-line analysis of the DATATOP cohort. The Parkinson Study Group. Neurology, 40, 1529-1534.
56. Goetz CG, PoeweW, Rascol O, Sampaio C, Stebbins GT, Counsell C, Giladi N, Holloway RG, Moore CG, Wenning GK, Yahr MD, & Seidl L (2004) Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale: Status and recommendations. Mov Disord, 19, 1020-1028.
57. Jost L (2007) Partitioning diversity into independent alpha and beta components. Ecology, 88, 2427-2439.
58. Goodrich JK, Di Rienzi SC, Poole AC, Koren O, Walters WA, Caporaso JG, Knight R, & Ley RE (2014) Conducting a microbiome study. Cell, 158, 250-262.
59. Itoh M, Furuse M, Morita K, Kubota K, Saitou M, & Tsukita S (1999) Direct binding of three tight junctionassociated MAGUKs, ZO-1, ZO-2, and ZO-3, with the COOH termini of claudins. J Cell Biol, 147, 1351-1363.
60. Fanning AS, Jameson BJ, Jesaitis LA, & Anderson JM (1998) The tight junction protein ZO-1 establishes a link between the transmembrane protein occludin and the actin cytoskeleton. J Biol Chem, 273, 29745-29753.
61. Bertiaux-Vandaele N, Youmba SB, Belmonte L, Lecleire S, Antonietti M, Gourcerol G, Leroi AM, Dechelotte P, Menard JF, Ducrotte P, & Coeffier M (2011) The expression and the cellular distribution of the tight junction proteins are altered in irritable bowel syndrome patients with differences according to the disease subtype. Am J Gastroenterol, 106, 2165-2173.
62. Bauer H, Zweimueller-Mayer J, Steinbacher P, Lametschwandtner A, & Bauer HC (2010) The dual role of zonula occludens (ZO) proteins. J Biomed Biotechnol, 2010, 402593.
63. Furuse M, Itoh M, Hirase T, Nagafuchi A, Yonemura S, & Tsukita S (1994) Direct association of occludin with ZO-1 and its possible involvement in the localization of occludin at tight junctions. J Cell Biol, 127, 1617-1626.
64. Umeda K, Matsui T, Nakayama M, Furuse K, Sasaki H, Furuse M, & Tsukita S (2004) Establishment and characterization of cultured epithelial cells lacking expression of ZO-1. J Biol Chem, 279, 44785-44794.
65. Caricilli AM, Castoldi A, & Camara NO (2014) Intestinal barrier: A gentlemen's agreement between microbiota and immunity. World J Gastrointest Pathophysiol, 5, 18-32.
66. Littman DR, & Pamer EG (2011) Role of the commensal microbiota in normal and pathogenic host immune responses. Cell Host Microbe, 10, 311-323.
67. Lathrop SK, Bloom SM, Rao SM, Nutsch K, Lio CW, Santacruz N, Peterson DA, Stappenbeck TS, & Hsieh CS (2011) Peripheral education of the immune system by colonic commensal microbiota. Nature, 478, 250-254.
68. Arpaia N, Campbell C, Fan X, Dikiy S, van der Veeken J, deRoos P, Liu H, Cross JR, Pfeffer K, Coffer PJ, & Rudensky AY (2013) Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation. Nature, 504, 451-455.
69. Lehnardt S, Lachance C, Patrizi S, Lefebvre S, Follett PL, Jensen FE, Rosenberg PA, Volpe JJ, & Vartanian T (2002) The toll-like receptor TLR4 is necessary for lipopolysaccharide-induced oligodendrocyte injury in the CNS. J Neurosci, 22, 2478-2486.
70. Lehnardt S (2009) Innate immunity and neuroinflammation in the CNS: The role of microglia in Toll-like receptor-mediated neuronal injury. Glia, 58, 253-263.
71. Gao HM, & Hong JS (2008) Why neurodegenerative diseases are progressive: Uncontrolled inflammation drives disease progression. Trends Immunol, 29, 357-365.
72. Guo S, Al-Sadi R, Said HM, & Ma TY (2013) Lipopolysaccharide causes an increase in intestinal tight junction permeability in vitro and in vivo by inducing enterocyte membrane expression and localization of TLR-4 and CD14. Am J Pathol, 182, 375-387.
73. Guo S, Nighot M, Al-Sadi R, Alhmoud T, Nighot P, & Ma TY (2015) Lipopolysaccharide regulation of intestinal tight junction permeability is mediated by TLR4 signal transduction pathway activation of FAK and MyD88. J Immunol, 195, 4999-5010.
74. Qin L, Wu X, Block ML, Liu Y, Breese GR, Hong JS, Knapp DJ, & Crews FT (2007) Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration. Glia, 55, 453-462.
75. Lu YC, Yeh WC, & Ohashi PS (2008) LPS/TLR4 signal transduction pathway. Cytokine, 42, 145-151.
76. Gayle DA, Ling Z, Tong C, Landers T, Lipton JW, & Carvey PM (2002) Lipopolysaccharide (LPS)-induced dopamine cell loss in culture: Roles of tumor necrosis factor-alpha, interleukin-1beta, and nitric oxide. Brain Res Dev Brain Res, 133, 27-35.
77. Stefanova N, Fellner L, Reindl M, Masliah E, Poewe W, & Wenning GK (2011) Toll-like receptor 4 promotes alpha-synuclein clearance and survival of nigral dopaminergic neurons. Am J Pathol, 179, 954-963.
78. Streit WJ, Mrak RE, & Griffin WS (2004) Microglia and neuroinflammation: A pathological perspective. J Neuroinflammation, 1, 14.
79. Fellner L, & Stefanova N (2013) The role of glia in alphasynucleinopathies. Mol Neurobiol, 47, 575-586.
80. Bsibsi M, Ravid R, Gveric D, & van Noort JM (2002) Broad expression of Toll-like receptors in the human central nervous system. J Neuropathol Exp Neurol, 61, 1013-1021.
81. Takeda K, & Akira S (2005) Toll-like receptors in innate immunity. Int Immunol, 17, 1-14.
82. Miller SI, Ernst RK, & Bader MW (2005) LPS, TLR4 and infectious disease diversity. Nat Rev Microbiol, 3, 36-46.
83. Block ML, Zecca L, & Hong JS (2007) Microgliamediated neurotoxicity: Uncovering the molecular mechanisms. Nat Rev Neurosci, 8, 57-69.
84. Cryan JF, & Dinan TG (2012) Mind-altering microorganisms: The impact of the gut microbiota on brain and behaviour. Nat Rev Neurosci, 13, 701-712.
85. Forsythe P, & Kunze WA (2013) Voices from within: Gut microbes and the CNS. Cell Mol Life Sci, 70, 55-69.
86. Ganapathy V, Thangaraju M, Prasad PD, Martin PM, & Singh N (2013) Transporters and receptors for short-chain fatty acids as the molecular link between colonic bacteria and the host. Curr Opin Pharmacol, 13, 869-874.
87. Maslowski KM, & Mackay CR (2011) Diet, gut microbiota and immune responses. Nat Immunol, 12, 5-9.
88. Rietschel ET, & Brade H (1992) Bacterial endotoxins. Sci Am, 267, 54-61.
89. Jellinger KA (2014) Neuropathology of multiple system atrophy: New thoughts about pathogenesis. Mov Disord, 29, 1720-1741.
90. Papp MI, Kahn JE, & Lantos PL (1989) Glial cytoplasmic inclusions in the CNS of patients with multiple system atrophy (striatonigral degeneration, olivopontocerebellar atrophy and Shy-Drager syndrome). J Neurol Sci, 94, 79-100.
91. Ozawa T, Paviour D, Quinn NP, Josephs KA, Sangha H, Kilford L, Healy DG, Wood NW, Lees AJ, Holton JL, & Revesz T (2004) The spectrum of pathological involvement of the striatonigral and olivopontocerebellar systems in multiple system atrophy: Clinicopathological correlations. Brain, 127, 2657-2671.
92. Tanji K, Mori F, Imaizumi T, Yoshida H, Matsumiya T, Tamo W, Yoshimoto M, Odagiri H, Sasaki M, Takahashi H, Satoh K, & Wakabayashi K (2002) Upregulation of alpha-synuclein by lipopolysaccharide and interleukin-1 in human macrophages. Pathol Int, 52, 572-577.
93. Uchihara T, & Giasson BI (2016) Propagation of alphasynuclein pathology: Hypotheses, discoveries, and yet unresolved questions from experimental and human brain studies. Acta Neuropathol, 131, 49-73.
94. Holmqvist S, Chutna O, Bousset L, Aldrin-Kirk P, Li W, Bjorklund T, Wang ZY, Roybon L, Melki R, & Li JY (2014) Direct evidence of Parkinson pathology spread from the gastrointestinal tract to the brain in rats. Acta Neuropathol, 128, 805-820.
95. Zhu L, Liu W, Alkhouri R, Baker RD, Bard JE, Quigley EM, & Baker SS (2014) Structural changes in the gut microbiome of constipated patients. Physiol Genomics, 46, 679-686.
96. Kim SE, Choi SC, Park KS, Park MI, Shin JE, Lee TH, Jung KW, Koo HS, & Myung SJ (2015) Change of fecal flora and effectiveness of the short-term VSL#3 probiotic treatment in patients with functional constipation. J Neurogastroenterol Motil, 21, 111-120.
97. Parthasarathy G, Chen J, Chen X, Chia N, O'Connor HM, Wolf PG, Gaskins HR, & Bharucha AE (2016) Relationship between microbiota of the colonic mucosa vs feces and symptoms, colonic transit, and methane production in female patients with chronic constipation. Gastroenterology, 150, 367-379 e361.
98. Suzuki A, Asahina M, Ishikawa C, Asahina KM, Honma K, Fukutake T, & Hattori T (2005) Impaired circadian rhythm of gastric myoelectrical activity in patients with multiple system atrophy. Clin Auton Res, 15, 368-372.
99. Chelimsky G, & Chelimsky TC (2003) Evaluation and treatment of autonomic disorders of the gastrointestinal tract. Semin Neurol, 23, 453-458.
100. Ozawa T, Tokunaga J, Arakawa M, Ishikawa A, Takeuchi R, Mezaki N, Miura T, Sakai N, Hokari M, Takeshima A, Utsumi K, Kondo T, Yokoseki A, & Nishizawa M (2013) Abnormal ghrelin secretion contributes to gastrointestinal symptoms in multiple system atrophy patients. J Neurol, 260, 2073-2077.